M. A. Valantin

Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients

M. A. Valantin, Randa Bittar, P. de Truchis et al. · Journal of Antimicrobial Chemotherapy · 2010 · 33 citations

Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens

Anne‐Geneviève Marcelin, C. Charpentier, Marc Wirden et al. · Journal of Antimicrobial Chemotherapy · 2012 · 27 citations · Full text

Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy

Sidonie Lambert-Niclot, Philippe Flandre, M. A. Valantin et al. · Journal of Antimicrobial Chemotherapy · 2012 · 19 citations · Full text

Role of treatment for depressive symptoms in relieving the impact of fatigue in HIVâHCV co-infected patients: ANRS Co13 Hepavih, France, 2006â2008

Laurent Michel, Virginie Villes, François Dabis et al. · Journal of Viral Hepatitis · 2009 · 13 citations

Low immune response rate of HIV-infected patients to a single injection of hepatitis A vaccine

Laure‐Hélène Noël, Roland Tubiana, Anne Simon et al. · Infectious Diseases Now · 2020 · 13 citations · Full text

Vaccination, Viral Hepatitis, Immunology +8